george bakris, md | use of finerenone in patients with diabetes who have kidney disease
Published 1 year ago • 4K plays • Length 34:04
Download video MP4
Download video MP3
Similar videos
-
3:07
dr george bakris compares fidelio-dkd renal outcomes with those of sglt-2 inhibitor trials
-
1:16
george bakris, md - university of chicago medicine
-
4:27
cardiovascular outcomes with finerenone in patients with ckd and diabetes
-
43:31
fidelio block-ckd dr. bakris (chicago)
-
9:14
"i'd rather die than have dialysis."
-
21:18
nattokinase: cardiovascular protection?
-
15:04
diabetic nephropathy - phases, risk factors, symptoms, diagnosis, treatment
-
19:55
improving renal outcomes with glucose-lowering therapy in the individualized management of t2dm
-
4:44
figaro-dkd trial results
-
17:59
dr. per-hernik groop - new ways to understand kidney disease in diabetes
-
0:39
role of finerenone in diabetic nephropathy or dkd patients #shorts #dkd
-
4:59
finerenone... adding life to years in kidney disease
-
3:41
jennifer green, easd 2022: finerenone & empagliflozin in patients with ckd and t2d: confidence study
-
25:41
26 mohamed tarik bakri new horizons in management of patients with ckd in t2d – role of finerenon
-
48:12
mineralocorticoid axis in health and disease- history, evolution and clinical implications
-
11:26
george bakris - irvine page alva bradley lifetime achievement award winner
-
9:00
finerenone medication review
-
29:23
finerenone in patients with diabetes and ckd
-
39:56
the role of novel nonsteroidal mineralocorticoid receptor antagonists in chronic kidney disease
-
2:12
how are ckd, cvd, and diabetes related? | the kidney disease, heart disease, and diabetes connection
-
15:20
dr. mathew john - newer molecules in diabetic kidney disease - finrenone
-
5:45
esc 2022: fidelity: finerenone in pts with chronic kidney disease | prof gerasimos filippatos
Clip.africa.com - Privacy-policy